Efficacy of Electroacupuncture (EA) for Women With Pure Stress Urinary Incontinence (SUI)
A Pilot Randomized Placebo Controlled Trial of Electroacupuncture for Women With Pure Stress Urinary Incontinence
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this study is to preliminarily assess the efficacy of electroacupuncture (EA) for women with pure stress urinary incontinence (SUI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 13, 2015
CompletedFirst Posted
Study publicly available on registry
May 15, 2015
CompletedResults Posted
Study results publicly available
June 15, 2015
CompletedJune 15, 2015
May 1, 2015
1.6 years
May 13, 2015
May 15, 2015
May 29, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change From Baseline of Urine Leakage Measured by 1-hour Pad Test
Baseline and week 6
Secondary Outcomes (3)
Change From Baseline of the 72-hour Incontinence Episode Frequency (IEF)
Baseline, weeks 1-6, weeks 15-18 and weeks 27-30
Change From Baseline of the Total ICIQ-SF Scores
Baseline, and weeks 6, 18 and 30
Patient Self-evaluation of Therapeutic Effect
weeks 6, 18 and 30
Other Outcomes (1)
Adverse Events
weeks 1-30
Study Arms (2)
EA group
ACTIVE COMPARATORSham EA group
PLACEBO COMPARATORInterventions
When acupuncturing, adhesive pads were first pasted on acupoints after sterilization in either group. In EA group, participants were needled at bilateral BL33 at an angle of 30 to 45 degree inward and downward, and at bilateral BL35 slightly toward upside and outside, to a depth of 50 to 60 mm using acupuncture needles of size 0.30×75 mm. Needles were then lifted, thrusted and twirled evenly for 3 times. Paired electrodes of EA apparatus were attached transversely to bilateral BL33 and BL35 (using real electrodes) respectively, with a continuous wave of 50 Hz and a current intensity of 1-5 milliampere (mA) for 30 min. Participants were treated with EA 3 sessions a week on alternate days for 6 successive weeks.
When acupuncturing, adhesive pads were first pasted on acupoints after sterilization in either group. In sham EA group, participants were needled at sham BL33 and sham BL35, which were about 20 mm lateral to BL33 and BL35, respectively, with blunt needle tips piercing adhesive pads and not piercing the surface of the skin, using placebo needles of size 0.30×25 mm. Needles were then lifted, thrusted and twirled evenly for 3 times. Paired electrodes of EA apparatus were attached transversely to bilateral sham BL33 and sham BL35 (using sham electrodes) respectively. The parameters of sham EA apparatus and the treatment course were the same as in the EA group.
Eligibility Criteria
You may qualify if:
- Eligible women were 40 to 75 years of age, and met the clinical diagnosis recommendations of SUI by the International Consultation on Urological Diseases:
- involuntary urine leakage on effort, exertion, sneezing or coughing which stopped when the stress ends;
- visible involuntary leakage from the urethra synchronous with increased abdominal pressure, or a pad weight gain \>1 g in 1-hour pad test;
- without symptoms of urinary frequency and urgency.
You may not qualify if:
- Women were excluded from the study if they met any of the following criteria: \*other type of urinary incontinence (UI) (urge, mixed, or overflow UI, etc);
- symptomatic urinary tract infection;
- ever received UI or pelvic surgery;
- a severity of pelvic organ prolapse ≥ degree 2;
- residual urinary volume \>30 ml;
- maximum flow rate ≤ 20 ml/s;
- limited in walking, stairs climbing and running;
- receiving specialized treatment for SUI, or taking medicine affecting bladder function;
- serious cardiovascular, cerebral, liver, kidney, or psychiatric disease, diabetes, multiple system atrophy, injury of cauda equina, or myeleterosis;
- being pregnant or breastfeeding;
- with cardiac pacemaker, metal allergy or severe needle phobia;
- unlike to give written formed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guang'anmen hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, 100053, China
Related Publications (1)
Xu H, Liu B, Wu J, Du R, Liu X, Yu J, Liu Z. A Pilot Randomized Placebo Controlled Trial of Electroacupuncture for Women with Pure Stress Urinary Incontinence. PLoS One. 2016 Mar 9;11(3):e0150821. doi: 10.1371/journal.pone.0150821. eCollection 2016.
PMID: 26960195DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Huanfang Xu
- Organization
- Guang'anmen hospital of China Academy of Chinese Medical Sciences
Study Officials
- PRINCIPAL INVESTIGATOR
Zhishun Liu, doctor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
May 13, 2015
First Posted
May 15, 2015
Study Start
December 1, 2012
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
June 15, 2015
Results First Posted
June 15, 2015
Record last verified: 2015-05